R. Goertsches

发表

Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy.

M. Hecker, U. Zettl, R. Goertsches, 2011, Pharmacogenomics.

Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis

S. Möller, H. Thiesen, U. Zettl, 2010, Autoimmunity.

Genetic factors in the autoimmune disease multiple sclerosis

R. Goertsches, 2006 .

Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients

M. Hecker, H. Thiesen, U. Zettl, 2013, Journal of Neuroinflammation.

MS therapy research applying genome-wide RNA profiling of peripheral blood.

U. Zettl, R. Goertsches, Zettl Uk, 2007, International MS journal.

Multiple sclerosis therapy monitoring based on gene expression.

Steffen Möller, Dirk Koczan, Pablo Serrano-Fernández, 2006, Current pharmaceutical design.

Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis

X. Montalban, Roland Martin, M. Comabella, 2006, Journal of Neuroimmunology.

Immunology and neurology

U. Zettl, R. Goertsches, E. Mix, 2007, Journal of Neurology.

United Europeans for development of pharmacogenomics in multiple sclerosis network.

Alexander V. Favorov, P. Villoslada, J. Oksenberg, 2009, Pharmacogenomics.

IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis

X. Montalban, J. Lechner-Scott, E. Urcelay, 2011, Journal of Neuroimmunology.

Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.

X. Montalban, M. Clanet, S. Vukusic, 2011, Brain : a journal of neurology.

Monitoring of multiple sclerosis immunotherapy

M. Hecker, U. Zettl, R. Goertsches, 2008, Journal of Neurology.

Monitoring of multiple sclerosis

M. Hecker, U. Zettl, R. Goertsches, 2008 .

Changes in the activation level of NF-kappa B in lymphocytes of MS patients during glucocorticoid pulse therapy

U. Zettl, R. Goertsches, G. Neeck, 2008, Journal of the Neurological Sciences.

Analysis of the IL28RA locus as genetic risk factor for multiple sclerosis

X. Montalban, E. Urcelay, K. Vandenbroeck, 2012, Journal of Neuroimmunology.

Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.

J. Ilonen, M. Ban, A. Goris, 2006 .

Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment

R Guthke, M. Hecker, R. Guthke, 2010, The Pharmacogenomics Journal.

Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis

M. Hecker, H. Hartung, H. Thiesen, 2011, PloS one.

Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS.

Dirk Koczan, Michael Hecker, M. Hecker, 2010, Pharmacogenomics.

Frequency, heterogeneity and encephalitogenicity of T cells specific for myelin oligodendrocyte glycoprotein in naive outbred primates

Pablo Villoslada, Nathan Heald, Robert Goertsches, 2001, European journal of immunology.

Integrative modeling of transcriptional regulation in response to antirheumatic therapy

Michael Hecker, Reinhard Guthke, Hans-Jürgen Thiesen, 2009, BMC Bioinformatics.

Detection of apoptotic cells in cerebrospinal fluid of patients suffering from neurological disease

U. Zettl, R. Goertsches, E. Mix, 2007, Journal of Neuroimmunology.

Immunoglobulins—Basic considerations

R. Goertsches, E. Mix, Uwe K. Zett, 2006, Journal of Neurology.

Plasma osteopontin levels in multiple sclerosis

X. Montalban, J. Río, M. Comabella, 2005, Journal of Neuroimmunology.

A genomic screen of Spanish multiple sclerosis patients reveals multiple loci associated with the disease

Pablo Villoslada, Arcadi Navarro, Xavier Montalban, 2003, Journal of Neuroimmunology.

Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis

Carlos Nos, Xavier Montalban, Manuel Comabella, 2008, Multiple sclerosis.

Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis

Arcadi Navarro, Xavier Montalban, Manuel Comabella, 2005, Journal of Neuroimmunology.

Association Cluster Detector: a tool for heuristic detection of significance clusters in whole-genome scans

Manuel Comabella, Xavier Montalban, Arcadi Navarro, 2005, ECCB/JBI.

Monoclonal antibodies in the therapy of multiple sclerosis

U. Zettl, R. Goertsches, O. Stüve, 2008, Journal of Neurology.

mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis

X. Montalban, H. Thiesen, M. Comabella, 2008, PloS one.

Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.

X. Montalban, M. Clanet, S. Vukusic, 2011, Brain : a journal of neurology.

Integrative modeling of transcriptional regulation in response to antirheumatic therapy

M. Hecker, R. Guthke, H. Thiesen, 2009, BMC Bioinformatics.

IL28B polymorphisms are not associated with the response to interferon-beta in multiple sclerosis

J. Lechner-Scott, J. Oksenberg, E. Urcelay, 2011, Journal of Neuroimmunology.